Rs. 160
Rs. 180
 11% off

ADEL Gelsemium Sempervirens Dilution 200

(10 ml Dilution in bottle)
Available in other variants
ADEL Gelsemium Sempervirens Dilution 200
Product Details
ADEL Gelsemium Sempervirens Dilution is a homeopathic remedy known for its profound effects on the nervous system, particularly in cases where there is a lack of coordination in various muscle groups. Derived from the yellow jasmine plant, this medicine is often indicated for individuals experiencing anxiety-related symptoms and feelings of loneliness. It is particularly useful for headaches accompanied by double vision or vertigo.

Key Ingredients:
  • Natural Minerals
  • Gelsemium Sempervirens
  • Lactose
  • Sucrose

Indications:
  • Blood pressure regulation
  • Respiratory issues
  • Anxiety and nervousness

Net Quantity:
11 ml

Product Form:
Liquid dilution

Key Benefits:
  • Anxiety Relief: Helps combat elevated blood pressure levels caused by anxiety, excitement, or sudden shock
  • Cold and Flu: Effective in managing symptoms of cold, flu, and sore throat
  • Nervousness: Alleviates nervousness experienced during examinations, job interviews, or presentations, whether in academic or professional settings
  • Headache and Vertigo: Addresses sensations of tightness in the head, heavy eyelids, double vision, and vertigo

Dosage:
  • Take 3-5 drops of ADEL Gelsemium Sempervirens Dilution
  • Administer two to three times a day or as recommended by a physician

Safety Information:
  • Read the label carefully before use
  • Use under medical supervision
  • Store in a cool, dry place away from direct sunlight
  • Keep out of reach of children
  • Avoid self-medication, consult a physician for appropriate dosage and usage

Frequently Asked Question
Q. Is Gelsemium Sempervirens Dilution safe for long-term use?
Gelsemium Sempervirens Dilution can be used for extended periods, but it is advisable to consult with a homeopathic practitioner for proper dosage and guidance, especially for prolonged usage.

Content on this page was last updated on 15 November, 2024, by Dr. Varun Gupta (MD Pharmacology)